<< Read Full Article

Forest Labs Antibiotic Meets Pneumonia Study Goals

Stock quotes in this article: FRX  

NEW YORK (AP) — Drug developer Forest Laboratories Inc. said Friday its developing antibiotic ceftaroline met key study goals in treating hospital-acquired pneumonia.

In two late-stage, or Phase III clinical trials, the drug had a higher cure rate than the antibiotic ceftriaxone in patients with moderate to severe forms of the condition.

The company expects to ask for Food and Drug Administration approval near the end of the year. ...

<< Read Full Article

Recent Comments

Loading .....




Dow Jones S&P 500 NASDAQ 10-Year Note
10,495.46 1,114.49 2,214.09 35.77
Oil *
73.67
UP
43.46
UP
6.56
UP
13.04
DOWN
0.26
10 Yr
3.58%
SPDR Gold
111.52
+0.42%
+0.59%
+0.59%
-0.72%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services